Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members

Journal of Ethnopharmacology

Volumn 112, Issue 3, 2007, Pages 507-513

  Santos, R G ^a   Landeira Fernandez, J ^b   Strassman, R J ^c   Motta, V ^a   Cruz, A P M ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ASI R; Ayahuasca; Banisteriopsis caapi; BHS; Emotional states; Psychotria viridis

Indexed keywords

AYAHUASCA; BANISTERIOPSIS CAAPI EXTRACT; HARMALINE; HARMINE; HARMOL; N,N DIMETHYLTRYPTAMINE; PSYCHEDELIC AGENT; PSYCHOTRIA VIRIDIS EXTRACT; TETRAHYDROHARMINE; UNCLASSIFIED DRUG;

ADULT; ANXIETY DISORDER; ARTICLE; BECK HOPELESSNESS SCALE; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG EFFECT; DRUG STRUCTURE; EMOTION; FEMALE; GAS CHROMATOGRAPHY; HOPELESSNESS; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETER; NORMAL HUMAN; PANIC; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIGION; STATE TRAIT ANXIETY INVENTORY;

ADULT; ANXIETY; BANISTERIOPSIS; BEVERAGES; BRAZIL; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FRUIT; HARMALINE; HARMINE; HUMANS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; N,N-DIMETHYLTRYPTAMINE; PANIC; PLANT EXTRACTS; PLANT LEAVES; PSYCHOMETRICS; QUESTIONNAIRES; RELIGION; TREATMENT OUTCOME;

BANISTERIOPSIS CAAPI; PSYCHOTRIA VIRIDIS;

EID: 34347368713     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.04.012     Document Type: Article

References (27)

1. Araújo W.S. Navegando sobre as ondas do Daime: história, cosmologia e ritual da Barquinha (1999), Ed. da Unicamp, São Paulo
2. Callaway J.C. A proposed mechanism for the visions of dream sleep. Medical Hypotheses 36 (1988) 119-124
3. Callaway J.C., Airaksinen M.M., McKenna D.J., Brito G., and Grob C.S. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116 (1994) 385-387
4. Callaway J.C., McKenna D.J., Grob C.S., Brito G.S., Raymon L.P., Poland R.E., Andrade E.N., Andrade E.O., and Mash D.C. Pharmacokinetics of Hoasca alkaloids in healthy humans. Journal of Ethnopharmacology 65 (1999) 243-256
5. Davis W. One River: Explorations and Discoveries in the Amazon Rain Forest (1997), Simon and Schuster Inc., Touchstone, New York
6. Deakin J.F.W., and Graeff F.G. 5-HT and mechanisms of defense. Journal of Psychopharmacology 5 (1991) 305-315
7. Frecska E., White K.D., and Luna L.E. Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation. Psychopharmacology 173 (2004) 79-87
8. Goulart, S.L., 2005. Contrastes e continuidades em uma tradição religiosa amazônica: os casos do Santo Daime, da Barquinha e UDV. In: Labate, B.C., Goulart, S.L. (Orgs.), O uso ritual das plantas de poder. Mercado de Letras, Campinas, pp. 355-396.
9. Graeff F.G., Guimarães F.S., de Andrade T.G., and Deakin J.F.W. Role of 5-HT in stress, anxiety and depression. Pharmacology Biochemistry and Behavior 54 (1996) 129-141
10. 2 serotonin receptors. Bioorganic and Medicinal Chemistry Letters 13 (2003) 4421-4425
11. Grob C.S., McKenna D.J., Callaway J.C., Brito G.S., Neves E.S., Oberlaender G., Saide O.L., Labigalini E., Tacla C., Miranda C.T., Strassman R.J., and Boone K.B. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brasil. Journal of Nervous and Mental Disease 184 (1996) 86-94
12. Grof S. LSD psychotherapy. Multidisciplinary Association for Psychedelic Studies (MAPS) (2001), Sarasota, Florida
13. Labate, B.C., Araújo, W.S. (Orgs.), 2004. O uso ritual da ayahuasca. Mercado de Letras, Campinas.
14. Luna, L.E., 2005. Narrativas da alteridade: a ayahuasca e o motivo de transformação em animal. In: Labate,B.C., Goulart, S.L. (Orgs.), O uso ritual das plantas de poder. Mercado de Letras, Campinas, pp. 333-354.
15. McKenna D.J., and Towers G.H.N. Ultra-violet mediated cytotoxic activity of beta-carboline alkaloids. Phytochemistry 20 (1981) 1001-1004
16. McKenna D.J., Towers G.H.N., and Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of Ayahuasca. Journal of Ethnopharmacology 10 (1984) 195-223
17. McKenna D.J., Repke D.B., Lo L., and Peroutka S.J. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29 (1990) 193-198
18. McKenna D.J., Callaway J.C., and Grob C.S. The scientific investigation of Ayahuasca: a review of past and current research. The Heffter Review of Psychedelic Research 1 (1998) 65-77
19. Nash, J.R., Nutt, D.J., 2005. Psychopharmacoterapy of Anxiety. Handbook of Experimental Pharmacology, Vol. 169, pp. 401-469.
20. Ott J. Ayahuasca Analogues: Pangaean Entheogens (1994), Natural Books Co., Kennewick, WA
21. Riba J., Rodrígues-Fornells A., Urbano G., Morte A., Antonijoan R., Monteiro M., Callaway J.C., and Barbanoj M.J. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology (Berl) 154 (2001) 85-95
22. Riba J., Valle M., Urbano G., Yritia M., Morte A., and Barbanoj M.J. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 306 (2003) 73-83
23. 2C serotonin receptors. Pharmacology Biochemistry and Behavior 61 (1998) 323-330
24. Starcevic V. Anxiety states: a review of conceptual and treatment issues. Current Opinion in Psychiatry 19 (2006) 79-83
25. Strassman R.J. Adverse reactions to psychedelic drugs: a review of the literature. The Journal of Nervous and Mental Disease 172 (1984) 577-595
26. Strassman R.J. DMT: The Spirit Molecule (2001), Park Street Press, Rochester, Vermont
27. Wikinski S. Depression and anxiety: from clinic to pharmacological treatment. Vertex 15 (2004) 208-212